According to a SNS Insider, the Nanotechnology Drug Delivery Market size was valued at USD 96.39 billion in 2024 and is projected to reach USD 200.77 billion by 2032. This reflects a strong compound ...

A new nanomedicine formulation method that uses the active pharmaceutical ingredient (API) as a scaffold rather than a separate matrix is a big breakthrough for biopharmaceutical manufacturers, says ...

The rise of AMR in pathogenic bacteria poses serious challenges to the control and management of infectious diseases.

This area of research has gained traction since its introduction in 1959 by the American physicist and Nobel Prize laureate, Richard Feynman. The versatility of this field can be almost said to be ...

Sapu Nano today announced new pharmacokinetic (PK) and tissue-distribution results demonstrating that Sapu003, the company's intravenous (IV) Deciparticle(TM) formulation of everolimus, substantially ...

Sapu Nano is a clinical-stage biotechnology company developing Deciparticle (TM) nanomedicine therapeutics designed to optimize the delivery of hydrophobic oncology agents and peptide-based ...

Nano-drug delivery techniques have expanded the possibilities for delivering a broad spectrum of biomolecular and synthetic therapeutic agents into a body target region. The characterization of ...

BIOMIND LABS ACCELERATES FDA PATHWAY FOR 5-MEO-DMT CANDIDATE BMND08 AND GRANTS STOCK OPTIONS TORONTO, ON / ACCESS Newswire / December 3, 2025 /Biomind Labs Inc. ("Biomind" or the "Company") (CBOE:BMND ...

Scientists in Israel have created the first nano-robot antibodies designed to fight cancer. The first human trial for the new nano-robots will start soon, and it will determine just how effective the ...